Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke

<div>Immunohistochemistry for GFP and NeuN. Panels (a) and (b) show fluorescent photomicrographs adjacent to the cerebral infarct 5 weeks posttransplantation in the BMSC/direct injection (a) and BMSC/scaffold (b) groups. Green: GFP; red: NeuN. Arrows indicate coexpressing cells. Scale bars: 25 <i>μ</i>m.</div>

Stem Cells International

fig6

Figure 6

Figure 6: Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke 